Vimarsana
Biggest News Aggregation in the World

Gunilla Andersson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gunilla Andersson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gunilla Andersson Today - Breaking & Trending Today

Mentice publishes the company's interim report for the period April – June 2023 - Vimarsana News

Mentice publishes the company's interim report for the period April – June 2023

Continued strong performance during the second quarter Significant events during the quarterMentice has received a significant repeat order for simulation solutions of approximately 2.4 MUSD,...

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 26 at 10:00 CEST - Vimarsana News

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 26 at 10:00 CEST

/PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for...

Mentice AB acquires all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L. - Vimarsana News

Mentice AB acquires all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.

STOCKHOLM, June 10, 2022 /PRNewswire/ --In accordance with the press release published on 9 June 2022, Mentice AB (publ) ("Mentice" or the "Company"), has entered into an agreement (the "Agreement") to acquire all assets relating to the software solution Ankyras ("Ankyras") from Galgo Medical S.L. ("Galgo") (the "Acquisition"), which was conditional on the receipt of external financing. In accordance with the press release published on 9 June 2022, Mentice has received such external financing through a directed new share issue and the...

Related Topics:
Gran MalmbergGunilla AnderssonCompany Certified AdviserNew ShareDirected New Share IssueNasdaq First North Premier Growth MarketCertified AdviserJune 10022 Prnewswire In Accordance With The Press Release Published On 9 June 2022Entice Ab Publ Quot Mentice Or The Company As Entered Into An Agreement The Quot To Acquire All Assets Relating Software Solution Ankyras From Galgo Medical Sl Acquisition Hich Was Conditional On The Receipt Of External Financing In Accordance With Press Release Published 9 June 2022Entice Has Received Such External Financing Througha Directed New Share Issue And Thereby Fulfilled The Condition Of In Agreement Acquisition MenticeS Published Ina Press Release On 9 June 2022Ntered Into An Agreement With Galgo To Acquire All Assets Related Ankyras For Amount Of Approximately Eur 1 80 Million Sek 18 78 Witha Possible Additional Purchase Price 0 975 10 17 Million1 Nd Witha Total Purchase Price Amounting To Approximately Eur 2 775 Million Sek 28 95 Million1 Be Paid In Cash The Completion Of Acquisition Has Been Conditional On Mentice Receiving Financing 9 June 2022Entice Announced The Implementation Ofa Directed New Share Issue Quot Through An Accelerated Book Building Procedure And Has Thus Received Financing For Acquisition More Information RegardingEea Separate Press Release Entitled Quot Mentice Ab Completesa Directed New Share Issue Of Approximately Sek 60 Million Which Was Significantly Oversubscribed Published Today Completion The Acquisition Is Expected In June 2022 For Additional InformationLease Contact Gran MalmbergEnticem Us 1 312 860 5610m Sweden 4670309 22 22e Goran Malmberg Mentice Com Gunilla AnderssonEnticem 4670213 71 38e Gunilla Andersson Mentice Com About Isa Global Market Leader Anda Company That Offers High Tech Solutions For Simulation To The Medical Sector Witha Focus On Fast Growing Endovascular Treatment Methods 39s Assist Specialists In Healthcare Regarding DevelopmentAnagement And Continuous Improvement Of Competence Technical Skills In Order To Positively Influence Patient Safety Quality Healthcare Mentice Solutions Are Scientifically Validated Specifically Developed For Specialists The Sector Medical Technology Industry NeurovascularArdiology And Peripheral Intervention Are Some Of The Specialty Areas Covered By Company 39s Solutions Visit Website For More InformationWw Mentice Com The Company 39s Shares Trade On Nasdaq First North Premier Growth MarketTockholm Ticker Mntc The Company 39s Certified Adviser Is Fnca Sweden Ab
Mentice AB intends to acquire all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L. - Vimarsana News

Mentice AB intends to acquire all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.

STOCKHOLM, June 10, 2022 /PRNewswire/ --Mentice AB (publ) ("Mentice" or the "Company"), a leading provider of high-tech solutions for decision support and productivity with the medical field of image guided interventional therapies, announces the intention to acquire all assets of the Ankyras software suite ("Ankyras") from Galgo Medical S.L. ("Galgo") for an amount of EUR 1.80 million (approximately SEK 18.78 million[1]) with a possible additional purchase amount of EUR 0.975 million (approximately SEK 10.17 million1), and with a total purchase consider...

Related Topics:
Comunidad Autonoma De CatalunaGran MalmbergUniversitat Pompeu FabraGunilla AnderssonDepartment Of Information TechnologiesMedical Device RegulationImage Guided Interventional TherapyAntoni RiuInformation TechnologiesAnnual Shareholders MeetingAbuse RegulationJune 10022 Prnewswire Mentice Ab Publ Quot Or The Company A Leading Provider Of High Tech Solutions For Decision Support And Productivity With The Medical Field Image Guided Interventional TherapiesNnounces The Intention To Acquire All Assets Of Ankyras Software Suite Quot From Galgo Medical Sl For An Amount Eur 1 80 Million Approximately Sek 18 78 Witha Possible Additional Purchase 0 975 10 17 Million1 Nd Witha Total Purchase Consideration Amounting To Approximately Eur 2 775 Million About Sek 28 95 Million1 Be Paid In Cash The Quot Acquisition Agreement And Completion Of Said Is Conditioned Upon Mentice Financing TransactionHich Is Planned To Be Performed Througha Directed New Share Issue 1 Eur Sek 10 4330 The Acquisition Related Precision Medicine Software Solutions For Area Of Neuro Interventional TherapiesPecifically For Planning And Analysis Regarding Preventive Treatment Cerebral Haemorrhage Aneurysms In The Brain Acquisition Is Company 39s First Within Area Of Precision Medicine Line With Strategic Direction That Has Previously Communicated Its Intention To Expand Vertically Field Therapy Image Based Interventions Characterized Asa Technology As This Solution An Early Phase Commercialization HoweverHe Solution Has Been Developed Fora Long Time By Galgo And The Software Ankyras Is Patent Protected Ce Marked Product Medical Device Regulation Mdr With Technology Published Since 2013 This Area For Treatments Of Aneurysms In Cerebral Arteries Brain Isa Growing Therapy One Causes Stroke Third Leading Cause Death Due To Illness Healthcare Largest World Lifelong Care Dependence Fifty People Estimated Have An Undetected Or Untreated Aneurysm That Potentially Can Lead Toa Haemorrhage Advanced Cloud Based Analysis Allowsa Physician Plan Treatment Specific Patient DoctorIth The Help Of AnkyrasElecta Suitable Clinical InstrumentE Type And SizeNd Then By Marking Where This Instrument Should Be Placed Obtain An Analysis Of How Well The Rests Against Vessel Wall And Effectively It Blocks Opening To Aneurysm Company Estimates That MarketHich Is Growing RapidlyUrrently Amounts To Approximately Sek 100 Million
Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million - Vimarsana News

Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE. STOCKHOLM, June 13, 2022 /PRNewswire/ --Mentice AB ("Mentice" or the "Company") hereby announces intention to carry out a directed new issu...